| related words |
| hematide |
| investigational |
| novel |
| nexavar |
| bidil |
| glucose |
| soliris |
| tarceva |
| recothrom |
| orphan |
| commercialized |
| feraheme |
| stent |
| biovaxid |
| protein |
| tablet |
| antibody |
| sublicense |
| increlex |
| cubicin |
|
| related documents |
| 899923--8/12/2010--MYRIAD_GENETICS_INC |
| 716646--6/15/2009--CLINICAL_DATA_INC |
| 716646--6/29/2006--CLINICAL_DATA_INC |
| 356591--3/25/2009--NEUROLOGIX_INC/DE |
| 921114--3/16/2006--TARGETED_GENETICS_CORP_/WA/ |
| 1001233--3/16/2006--SANGAMO_BIOSCIENCES_INC |
| 1022974--3/31/2009--DECODE_GENETICS_INC |
| 934473--3/15/2006--GENVEC_INC |
| 1003929--3/20/2006--CORAUTUS_GENETICS_INC |
| 356591--3/26/2010--NEUROLOGIX_INC/DE |
| 819050--2/25/2010--VICAL_INC |
| 1076481--3/16/2010--SEQUENOM_INC |
| 934473--3/17/2008--GENVEC_INC |
| 1001233--3/5/2010--SANGAMO_BIOSCIENCES_INC |
| 1396238--3/31/2010--IRIS_BIOTECHNOLOGIES_INC |
| 921114--3/29/2007--TARGETED_GENETICS_CORP_/WA/ |
| 1001233--3/1/2007--SANGAMO_BIOSCIENCES_INC |
| 934473--3/16/2007--GENVEC_INC |
| 921114--3/31/2009--TARGETED_GENETICS_CORP_/WA/ |
| 899923--8/26/2009--MYRIAD_GENETICS_INC |
|
| related topics |
| {product, candidate, development} |
| {product, liability, claim} |
| {cost, contract, operation} |
| {property, intellectual, protect} |
| {control, financial, internal} |
| {provision, law, control} |
| {cost, regulation, environmental} |
| {loss, insurance, financial} |
| {stock, price, operating} |
| {debt, indebtedness, cash} |
| {investment, property, distribution} |
| {product, market, service} |
| {stock, price, share} |
| {operation, international, foreign} |
| {regulation, change, law} |
| {customer, product, revenue} |
| {gas, price, oil} |
| {tax, income, asset} |
| {regulation, government, change} |
| {financial, litigation, operation} |
|